相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。P53 and The Immune Response: 40 Years of Exploration-A Plan for the Future
Arnold J. Levine
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting
Y. -R. Yu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Parisa Malekzadeh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State
Jae Hyuk Yoo et al.
CANCER RESEARCH (2019)
The senescence-associated secretory phenotype and its regulation
Stephane Lopes-Paciencia et al.
CYTOKINE (2019)
The Small GTPase Arf6: An Overview of Its Mechanisms of Action and of Its Role in Host-Pathogen Interactions and Innate Immunity
Tim Van Acker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer
Man Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
Max D. Wellenstein et al.
NATURE (2019)
Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment
Jing Wang et al.
CANCER MEDICINE (2019)
TP53 Mutations Promote Immunogenic Activity in Breast Cancer
Zhixian Liu et al.
JOURNAL OF ONCOLOGY (2019)
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Tianyi Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
Alexander Thiem et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
Shigeru Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition
Yilun Wu et al.
FRONTIERS IN IMMUNOLOGY (2019)
p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
Kaori Fujita
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Awakening the guardian of genome: reactivation of mutant p53
Akshay Binayke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
Anna E. Vilgelm et al.
FRONTIERS IN IMMUNOLOGY (2019)
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53
Maximiliane Schuldner et al.
THERANOSTICS (2019)
Unmasking senescence: context-dependent effects of SASP in cancer
Douglas V. Faget et al.
NATURE REVIEWS CANCER (2019)
T-cell Responses to TP53 Hotspot Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
Drew C. Deniger et al.
CLINICAL CANCER RESEARCH (2018)
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors
Madhav D. Sharma et al.
IMMUNITY (2018)
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein et al.
IMMUNITY (2018)
STAT3/p53 pathway activation disrupts IFN-beta-induced dormancy in tumor-repopulating cells
Yuying Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms
Marco Bezzi et al.
NATURE MEDICINE (2018)
Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features
Sharathchandra Arandkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Distinctive profiles of tumor-infiltrating immune cells and association with intensity of infiltration in colorectal cancer
Yugang Wu et al.
ONCOLOGY LETTERS (2018)
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
Tomer Cooks et al.
NATURE COMMUNICATIONS (2018)
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
Kamil Lisek et al.
Oncotarget (2018)
Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway
Yun Zhou et al.
CANCER MEDICINE (2018)
p53 and the Viral Connection: Back into the Future
Ronit Aloni-Grinstein et al.
CANCERS (2018)
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
Ikuno Uehara et al.
CANCERS (2018)
Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion
Ramona Schulz-Heddergott et al.
CANCER CELL (2018)
Innate Lymphoid Cells: 10 Years On
Eric Vivier et al.
CELL (2018)
Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management
Andrea Nicolini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer
Zehang Jiang et al.
TRANSLATIONAL ONCOLOGY (2018)
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
Xiaohong Cen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells
Haruka Handa et al.
CELL COMMUNICATION AND SIGNALING (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Role of Extracellular Matrix in Development and Cancer Progression
Cameron Walker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression
Ivano Amelio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
From inflammation to cancer
A. Korniluk et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2017)
Cancer and inflammation
Lance L. Munn
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2017)
Roles of Arf6 in cancer cell invasion, metastasis and proliferation
Rui Li et al.
LIFE SCIENCES (2017)
Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis
Thomas M. Vallance et al.
MEDIATORS OF INFLAMMATION (2017)
p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes
Kyrie Pappas et al.
MOLECULAR CANCER RESEARCH (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Census and evaluation of p53 target genes
M. Fischer
ONCOGENE (2017)
TLR1-10, NF-κB and p53 expression is increased in oral lichenoid disease
Peter Rusanen et al.
PLOS ONE (2017)
Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling
Homa Rahnamoun et al.
NATURE COMMUNICATIONS (2017)
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Helen Ha et al.
THERANOSTICS (2017)
Hypoxia-inducible factor-1 alpha Correlates with Tumor-Associated Macrophages Infiltration, Influences Survival of Gastric Cancer Patients
Wei-jie Zhang et al.
JOURNAL OF CANCER (2017)
Role of tumor microenvironment in tumorigenesis
Maonan Wang et al.
JOURNAL OF CANCER (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
The mutational status of p53 can influence its recognition by human T-cells
Katerina Shamalov et al.
ONCOIMMUNOLOGY (2017)
Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity
Gang Guo et al.
CANCER RESEARCH (2017)
TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis
Kirill V. Korneev et al.
CYTOKINE (2017)
Long story short: p53 mediates innate immunity
Jessica Miciak et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier
Patrick Vianna Garcia et al.
BMC CANCER (2016)
Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils
Yanfang Liu et al.
CANCER CELL (2016)
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis
Marco Cordani et al.
CANCER LETTERS (2016)
Lack of p53 Augments Antitumor Functions in Cytolytic T Cells
Anirban Banerjee et al.
CANCER RESEARCH (2016)
Novel combination of serum microRNA for detecting breast cancer in the early stage
Akihiko Shimomura et al.
CANCER SCIENCE (2016)
Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
Sonja M. Woermann et al.
GASTROENTEROLOGY (2016)
Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment
Yan Cui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
P53-and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance
Ari Hashimoto et al.
JOURNAL OF CELL BIOLOGY (2016)
Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer
Gwangil Kim et al.
LUNG CANCER (2016)
COX-2 inhibitor NS-398 suppresses doxorubicin-induced p53 accumulation through inhibition of ROS-mediated Jnk activation
Joohwee Kim et al.
MOLECULAR CARCINOGENESIS (2016)
The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression
Marco Tafani et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
Bernhard Mlecnik et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression
Wen Cai Zhang et al.
NATURE COMMUNICATIONS (2016)
Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells
Daniel Menendez et al.
ONCOTARGET (2016)
p53 and the Carcinogenicity of Chronic Inflammation
Andrei V. Gudkov et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
Pankita H. Pandya et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Transcriptional analysis of immune-related gene expression in p53-deficient mice with increased susceptibility to influenza A virus infection
Wenjun Yan et al.
BMC MEDICAL GENOMICS (2015)
Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses
Le Jiang et al.
CELL CYCLE (2015)
The role of CD95 and CD95 ligand in cancer
M. E. Peter et al.
CELL DEATH AND DIFFERENTIATION (2015)
Heme Oxygenase-1 Determines the Differential Response of Breast Cancer and Normal Cells to Piperlongumine
Ha-Na Lee et al.
MOLECULES AND CELLS (2015)
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth
Svasti Haricharan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A p53-regulated immune checkpoint relevant to cancer
Laurence Zitvogel et al.
SCIENCE (2015)
Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53
Kyoung Wan Yoon et al.
SCIENCE (2015)
Senescence-associated inflammatory responses: aging and cancer perspectives
Audrey Lasry et al.
TRENDS IN IMMUNOLOGY (2015)
p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways
Maria Shatz et al.
ONCOTARGET (2015)
p53 in the Myeloid Lineage Modulates an Inflammatory Microenvironment Limiting Initiation and Invasion of Intestinal Tumors
Xue-Yan He et al.
CELL REPORTS (2015)
Human Tumor Antigens and Cancer Immunotherapy
Nathalie Vigneron
BIOMED RESEARCH INTERNATIONAL (2015)
MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing
M. Neerincx et al.
ONCOGENESIS (2015)
A unique role for p53 in the regulation of M2 macrophage polarization
L. Li et al.
CELL DEATH AND DIFFERENTIATION (2015)
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53
David Quigley et al.
MOLECULAR CANCER RESEARCH (2015)
Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist
V. Ubertini et al.
ONCOGENE (2015)
Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis
Marica Garziera et al.
PLOS ONE (2015)
Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche
Pan Pantziarka
ECANCERMEDICALSCIENCE (2015)
p53 and NF-κB Coregulate Proinflammatory Gene Responses in Human Macrophages
Julie M. Lowe et al.
CANCER RESEARCH (2014)
Caught in the cross fire: p53 in inflammation
Tomer Cooks et al.
CARCINOGENESIS (2014)
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Susann Weissmueller et al.
CELL (2014)
CD147: A Novel Modulator of Inflammatory and Immune Disorders
X. Zhu et al.
CURRENT MEDICINAL CHEMISTRY (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
The Small GTPase Arf6 Is Essential for the Tram/Trif Pathway in TLR4 Signaling
Tim Van Acker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP
Giulio Di Minin et al.
MOLECULAR CELL (2014)
The Yin and Yang of Toll-like receptors in cancer
J-P Pradere et al.
ONCOGENE (2014)
Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis
Huan Yang et al.
PLOS ONE (2014)
Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity
Li Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Peptides genetically selected for NF-κB activation cooperate with oncogene Ras and model carcinogenic role of inflammation
Venkatesh Natarajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers
Haiyang Yu et al.
NATURE COMMUNICATIONS (2014)
Adaptive resistance to immunotherapy directed against p53 can be overcome by global expression of tumor-antigens in dendritic cells
Matjaz Humer et al.
FRONTIERS IN ONCOLOGY (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Changes in COX-2 and oxidative damage factors during differentiation of human mesenchymal stem cells to hepatocyte-like cells is associated with downregulation of P53 gene
Safoura Khajeniazi et al.
BIOLOGICAL CHEMISTRY (2013)
Loss of p53 in Enterocytes Generates an Inflammatory Microenvironment Enabling Invasion and Lymph Node Metastasis of Carcinogen-Induced Colorectal Tumors
Sarah Schwitalla et al.
CANCER CELL (2013)
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
Tomer Cooks et al.
CANCER CELL (2013)
Trp53 Inactivation in the Tumor Microenvironment Promotes Tumor Progression by Expanding the Immunosuppressive Lymphoid-like Stromal Network
Gang Guo et al.
CANCER RESEARCH (2013)
Non-Cell-Autonomous Tumor Suppression by p53
Amaia Lujambio et al.
CELL (2013)
Loss of p53 in stromal fibroblasts promotes epithelial cell invasion through redox-mediated ICAM1 signal
Dunyaporn Trachootham et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Alexandre Iannello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Tumor Suppressor p53 Inhibits Systemic Autoimmune Diseases by Inducing Regulatory T Cells
Hirotoshi Kawashima et al.
JOURNAL OF IMMUNOLOGY (2013)
TLR agonists: our best frenemy in cancer immunotherapy
Sabina Kaczanowska et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts- Secreted Interferon Beta
Shalom Madar et al.
PLOS ONE (2013)
Clinical utility of anti-p53 auto-antibody: Systematic review and focus on colorectal cancer
Aravind Suppiah et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1
Bei Wang et al.
NATURE COMMUNICATIONS (2013)
Tumor cell-macrophage interactions increase angiogenesis through secretion of EMMPRIN
Bat-Chen Amit-Cohen et al.
FRONTIERS IN PHYSIOLOGY (2013)
Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin
Jens O. Schmid et al.
CANCER RESEARCH (2012)
The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells
Maria Shatz et al.
CANCER RESEARCH (2012)
Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration
W. Andrew Yeudall et al.
CARCINOGENESIS (2012)
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
P. Allavena et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
The application of Toll like receptors for cancer therapy
Eui Young So et al.
International Journal of Biological Sciences (2012)
Differential Constitutive and Cytokine-Modulated Expression of Human Toll-like Receptors in Primary Neutrophils, Monocytes, and Macrophages
D. Shane O'Mahony et al.
International Journal of Medical Sciences (2012)
Regulation of CXCR4 gene expression in breast cancer cells under diverse stress conditions
Kleopatra Andreou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Interferon-β Induces Cellular Senescence in Cutaneous Human Papilloma Virus-Transformed Human Keratinocytes by Affecting p53 Transactivating Activity
Maria V. Chiantore et al.
PLOS ONE (2012)
Inhibitory Effect of Tumor Suppressor p53 on Proinflammatory Chemokine Expression in Ovarian Cancer Cells by Reducing Proteasomal Degradation of IκB
Deok-Soo Son et al.
PLOS ONE (2012)
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Suzanne Ostrand-Rosenberg et al.
SEMINARS IN CANCER BIOLOGY (2012)
Crosstalk between Complement and Toll-Like Receptors
Wen-Chao Song
TOXICOLOGIC PATHOLOGY (2012)
Dysregulation of anti-tumor immunity by the matrix metalloproteinase-2
Emmanuelle Godefroy et al.
ONCOIMMUNOLOGY (2012)
The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment
Ning Li et al.
CANCER CELL (2011)
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
Salome Gonzalez-Reyes et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
Sonja Textor et al.
CANCER RESEARCH (2011)
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
Yuchen Chien et al.
GENES & DEVELOPMENT (2011)
Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies
R. Vermeij et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Curaxins: Anticancer Compounds that Simultaneously Suppress NF-κB and Activate p53 by Targeting FACT
Alexander V. Gasparian et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The Toll-Like Receptor Gene Family Is Integrated into Human DNA Damage and p53 Networks
Daniel Menendez et al.
PLOS GENETICS (2011)
Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
Salome Gonzalez-Reyes et al.
BMC CANCER (2010)
High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
E. L. Wang et al.
BRITISH JOURNAL OF CANCER (2010)
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
Neta Erez et al.
CANCER CELL (2010)
p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner
Yoseph Addadi et al.
CANCER RESEARCH (2010)
TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis
Manabu Taura et al.
CANCER SCIENCE (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Sergei I. Grivennikov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
AIP1 Functions as Arf6-GAP to Negatively Regulate TLR4 Signaling
Ting Wan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Foxp3 Expression in p53-dependent DNA Damage Responses
Da-Jung Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Research Regulation of MCP-1 chemokine transcription by p53
Katrin Hacke et al.
MOLECULAR CANCER (2010)
Cross talk between stimulated NF-κB and the tumor suppressor p53
G. Schneider et al.
ONCOGENE (2010)
Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
Jacqueline D. Shields et al.
SCIENCE (2010)
Crosstalk pathways between Toll-like receptors and the complement system
George Hajishengallis et al.
TRENDS IN IMMUNOLOGY (2010)
Dual Role of p53 in Innate Antiviral Immunity
Carmen Rivas et al.
VIRUSES-BASEL (2010)
EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2α-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2
Faten Bougatef et al.
BLOOD (2009)
A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells
Hua Zhu et al.
CANCER BIOLOGY & THERAPY (2009)
The contribution of direct TLR signaling to T cell responses
Adeeb H. Rahman et al.
IMMUNOLOGIC RESEARCH (2009)
p53 Attenuates Lipopolysaccharide-Induced NF-κB Activation and Acute Lung Injury
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
NF-κB: A Key Player in Lung Cancer
[Anonymous]
CELL (2009)
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
Giulia Fontemaggi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Cancer cells suppress p53 in adjacent fibroblasts
J. Bar et al.
ONCOGENE (2009)
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Etienne Meylan et al.
NATURE (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Activated p53 induces NF-κB DNA binding but suppresses its transcriptional activation
Keiko Kawauchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine
A. C. Dudley et al.
BRITISH JOURNAL OF CANCER (2008)
Self-tolerance does not restrict the CD4+T-helper response against the p53 tumor antigen
Marjolein M. Lauwen et al.
CANCER RESEARCH (2008)
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-α-dependent mechanism
Alessio Paone et al.
CARCINOGENESIS (2008)
Development of multi-epitope vaccines targeting wild-type-sequence p53 peptides
Albert B. DeLeo et al.
EXPERT REVIEW OF VACCINES (2008)
ROS and p53: A versatile partnership
Bin Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
IL-24 Induces Apoptosis of Chronic Lymphocytic Leukemia B Cells Engaged into the Cell Cycle through Dephosphorylation of STAT3 and Stabilization of p53 Expression
Alexander Sainz-Perez et al.
JOURNAL OF IMMUNOLOGY (2008)
p53 Regulates Toll-Like Receptor 3 Expression and Function in Human Epithelial Cell Lines
Manabu Taura et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Anwesha Dey et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Breast-cancer stromal cells with TP53 mutations and nodal metastases
Attila Patocs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Toll-like receptors' two-edged sword: when immunity meets apoptosis
Bruno Salaun et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer
Marion E. Couch et al.
CLINICAL CANCER RESEARCH (2007)
TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells
Tom A. Barr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Nutlin-3 inhibits the NFκB pathway in a p53-dependent manner implications in lung cancer therapy
Anwesha Dey et al.
CELL CYCLE (2007)
FOXP3 regulates TLR10 expression in human T regulatory cells
Michael P. Bell et al.
JOURNAL OF IMMUNOLOGY (2007)
TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance
Weigang He et al.
MOLECULAR IMMUNOLOGY (2007)
Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray
Huachuan Zheng et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts
Neta Moskovits et al.
CANCER RESEARCH (2006)
Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR (vol 175, pg 5799, 2005)
C. J. Cohen et al.
JOURNAL OF IMMUNOLOGY (2006)
Stromal fibroblasts in cancer - A novel tumor-promoting cell type
Akira Orimo et al.
CELL CYCLE (2006)
Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1
C Tsatsanis et al.
JOURNAL OF IMMUNOLOGY (2006)
Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells
D Yoshida et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
PIDD mediates NF-κB activation in response to DNA damage
S Janssens et al.
CELL (2005)
Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors
KV Gurova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immune responses to p53 in patients with cancer:enrichment in tetramer+p53 peptide-specific T cells and regulatory T cells at tumor sites
AE Albers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Immunologic aspect of ovarian cancer and p53 as tumor antigen
HW Nijman et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Role of Stat3 in regulating p53 expression and function
GL Niu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Down-regulation of p53 by double-stranded RNA modulates the antiviral response
JT Marques et al.
JOURNAL OF VIROLOGY (2005)
Immunization with mutant p53- and K-ras-derived peptides in cancer patients:: Immune response and clinical outcome
DP Carbone et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation
DJ Tomso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function
SJ Zheng et al.
DIABETES (2005)
Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis
CA Corcoran et al.
ONCOGENE (2005)
Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB
K Asehnoune et al.
JOURNAL OF IMMUNOLOGY (2004)
Human tumor suppressor p53 and DNA viruses
S Collot-Teixeira et al.
REVIEWS IN MEDICAL VIROLOGY (2004)
Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck
N Sirianni et al.
CLINICAL CANCER RESEARCH (2004)
Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
A Takaoka et al.
NATURE (2003)
Molecular genetic alterations in the laser-capture microdissected stroma adjacent to bladder carcinoma
RF Paterson et al.
CANCER (2003)
Extracellular matrix-regulated p53 expression and nuclear localization in cultured Detroit 562 cells derived from pharyngeal carcinoma
LN Li et al.
ARCHIVES OF HISTOLOGY AND CYTOLOGY (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas
K Kurose et al.
NATURE GENETICS (2002)
p53-mediated induction of Cox-2 counteracts p53-or genotoxic stress-induced apoptosis
JA Han et al.
EMBO JOURNAL (2002)
p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3
J Lin et al.
ONCOGENE (2002)
Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53
T Mori et al.
ONCOGENE (2002)
Frequent co-localization of cox-2 and laminin-5 gamma 2 chain at the invasive front of early-stage lung adenocarcinomas
T Niki et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
EMMPRIN-mediated MMP regulation in tumor and endothelial cells
S Caudroy et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization
A Alexandrova et al.
ONCOGENE (2000)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells
E Toschi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
M Muzio et al.
JOURNAL OF IMMUNOLOGY (2000)
Role of NF-κB in p53-mediated programmed cell death
KM Ryan et al.
NATURE (2000)
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)
N Yen et al.
CANCER GENE THERAPY (2000)
分享论文
